{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T03:49:18Z","timestamp":1789530558810,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["Ho 4392\/1-1"],"award-info":[{"award-number":["Ho 4392\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Strategischer Forschungsfonds der Universit\u00e4t D\u00fcsseldorf"},{"name":"Deutsche Multiple Sklerose Gesellschaft"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.intimp.2013.06.023","type":"journal-article","created":{"date-parts":[[2013,7,15]],"date-time":"2013-07-15T15:45:26Z","timestamp":1373903126000},"page":"427-431","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Induction of pro-inflammatory cytokine production in thymocytes by the immune response modifiers Imiquimod and Gardiquimod\u2122"],"prefix":"10.1016","volume":"17","author":[{"given":"Andreas","family":"Weber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne K.","family":"Mausberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd C.","family":"Kieseier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Peter","family":"Hartung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald H.","family":"Hofstetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2013.06.023_bb0005","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.intimp.2013.06.023_bb0010","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.intimp.2013.06.023_bb0015","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.intimp.2013.06.023_bb0020","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cyto.2006.04.014","article-title":"IL-17 production by thymocytes upon CD3 stimulation and costimulation with microbial factors","volume":"34","author":"Hofstetter","year":"2006","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2013.06.023_bb0025","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1084\/jem.20110680","article-title":"The requirements for natural Th17 cell development are distinct from those of conventional Th17 cells","volume":"208","author":"Kim","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2013.06.023_bb0030","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/ni.1783","article-title":"Thymic self-reactivity selects natural interleukin 17-producing T cells that can regulate peripheral inflammation","volume":"10","author":"Marks","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.intimp.2013.06.023_bb0035","doi-asserted-by":"crossref","first-page":"7523","DOI":"10.4049\/jimmunol.0803828","article-title":"Natural occurring IL-17 producing T cells regulate the initial phase of neutrophil mediated airway responses","volume":"183","author":"Tanaka","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.06.023_bb0040","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cyto.2012.01.010","article-title":"Ex vivo activation of naturally occurring IL-17-producing T cells does not require IL-6","volume":"58","author":"Smolianov","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2013.06.023_bb0045","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1084\/jem.20110128","article-title":"NIK signaling in dendritic cells but not in T cells is required for the development of effector T cells and cell-mediated immune responses","volume":"208","author":"Hofmann","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2013.06.023_bb0050","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev.immunol.21.120601.141126","article-title":"Toll-like receptors","volume":"21","author":"Takeda","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.intimp.2013.06.023_bb0055","doi-asserted-by":"crossref","first-page":"19008","DOI":"10.1074\/jbc.M311618200","article-title":"Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the Toll-like receptors","volume":"279","author":"Nishiya","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.intimp.2013.06.023_bb0060","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/cmi.2010.30","article-title":"The TLR7 agonists imiquimod and gardiquimod improve DC-based immunotherapy for melanoma in mice","volume":"7","author":"Ma","year":"2010","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.intimp.2013.06.023_bb0065","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/sj.onc.1210913","article-title":"TLR7 and TLR8 as targets in cancer therapy","volume":"27","author":"Schon","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2013.06.023_bb0070","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1002\/ijc.25302","article-title":"Imiquimod-induced clearance of HPV is associated with normalization of immune cell counts in usual type vulvar intraepithelial neoplasia","volume":"127","author":"Terlou","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.intimp.2013.06.023_bb0075","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/sti.2010.047431","article-title":"Topical imiquimod treatment of aciclovir-resistant herpes simplex disease: case series and literature review","volume":"87","author":"Perkins","year":"2011","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.intimp.2013.06.023_bb0080","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/CJI.0b013e318209eed4","article-title":"Topical imiquimod has therapeutic and immunomodulatory effects against intracranial tumors","volume":"34","author":"Xiong","year":"2011","journal-title":"J Immunother"},{"key":"10.1016\/j.intimp.2013.06.023_bb0085","doi-asserted-by":"crossref","first-page":"6646","DOI":"10.1073\/pnas.0631696100","article-title":"Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7","volume":"100","author":"Lee","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.intimp.2013.06.023_bb0090","first-page":"702","article-title":"Masked oral prodrugs of toll-like receptor 7 agonists: a new approach for the treatment of infectious disease","volume":"7","author":"Fletcher","year":"2006","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.intimp.2013.06.023_bb0095","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1172\/JCI61862","article-title":"Rorgammat+ innate lymphocytes and gammadelta T cells initiate psoriasiform plaque formation in mice","volume":"122","author":"Pantelyushin","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.intimp.2013.06.023_bb0100","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1182\/blood-2008-04-151712","article-title":"Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology","volume":"113","author":"Baenziger","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2013.06.023_bb0105","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00011-010-0265-6","article-title":"Stimulation of TLR7 prior to polymicrobial sepsis improves the immune control of the inflammatory response in adult mice","volume":"60","author":"Koerner","year":"2011","journal-title":"Inflamm Res"},{"key":"10.1016\/j.intimp.2013.06.023_bb0110","doi-asserted-by":"crossref","first-page":"e17940","DOI":"10.1371\/journal.pone.0017940","article-title":"Acute endotoxin-induced thymic atrophy is characterized by intrathymic inflammatory and wound healing responses","volume":"6","author":"Billard","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2013.06.023_bb0115","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.4049\/jimmunol.152.10.5014","article-title":"Sepsis-induced apoptosis of the thymocytes in mice","volume":"152","author":"Wang","year":"1994","journal-title":"J Immunol"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576913002646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576913002646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T05:31:08Z","timestamp":1688362268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576913002646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1567576913002646"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2013.06.023","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induction of pro-inflammatory cytokine production in thymocytes by the immune response modifiers Imiquimod and Gardiquimod\u2122","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2013.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}